Commentary: metformin use is associated with reduced gastric cancer risk - authors' reply

被引：1

作者：

Kim, Y. -I. ^{[1
]}

Cho, S. -J. ^{[1
]}

机构：

[1] Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 10期

关键词：

D O I：

10.1111/apt.12740

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1239 / 1240

页数：2

共 4 条

[1]

de Vries AC, 2014, ALIMENT PHARM THER, V39, P1239, DOI 10.1111/apt.12723

[2] Diabetes and Cancer A consensus report [J].

Giovannucci, Edward ;

Harlan, David M. ;

Archer, Michael C. ;

Bergenstal, Richard M. ;

Gapstur, Susan M. ;

Habel, Laurel A. ;

Pollak, Michael ;

Regensteiner, Judith G. ;

Yee, Douglas .

DIABETES CARE, 2010, 33 (07) :1674-1685

[3] Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study [J].

Kim, Y. -I. ;

Kim, S. Y. ;

Cho, S. -J. ;

Park, J. -H. ;

Choi, I. J. ;

Lee, Y. J. ;

Lee, E. K. ;

Kook, M. -C. ;

Kim, C. G. ;

Ryu, K. W. ;

Kim, Y. -W. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (08) :854-863

[4] Diabetes and gastric cancer: the potential links [J].

Tseng, Chin-Hsiao ;

Tseng, Farn-Hsuan .

WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (07) :1701-1711

← 1 →